The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

LEVEL OF ADRENO-CORTICAL SUBSTANCE IN THE BLOOD DURING HYPOGLYCEMIC TREATMENTS FOR SCHIZOPHRENIA

Published Online:https://doi.org/10.1176/ajp.99.1.75

1. Chemical studies on the levels of adrenalin-cortical material in the blood show marked differences in the cases who recover from insulin shock therapy as compared with those who fail to recover.

2. The curves of recovered cases are characterized by a rising residual A-C level and a stability in the amounts present even under the stress of hypoglycemic coma and electric shock.

3. Failures are characterized by a persistently low A-C value with great susceptibility to change when shocks are applied.

4. The significance of these findings for an understanding of schizophrenia is discussed.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.